The FDA has approved Leqembi Iqlik, a subcutaneous, autoinjector formulation for maintenance dosing in people with early Alzheimer's disease ...

September is World Alzheimer’s Month, and the global Alzheimer’s disease community is looking to raise awareness and combat ...